A Arginin-glycin-aspartat-mimetic, reversibly binds to platelets to reduce the risk of cardiac ischemic events.
相关文献及参考
Giugliano, R., et al.: New Eng. J. Med., 360, 2176 (2009),
Hantgan, R., et al.: Biochem., 48, 8355 (2009),
Pathak, A., et al.: Cardiovas. Diabetol., 7 (2008),
[1]. Gilchrist IC, et al. Platelet glycoprotein IIb/IIIa inhibitors in percutaneous coronary intervention: focus on the pharmacokinetic-pharmacodynamic relationships of eptifibatide. Clin Pharmacokinet. 2003;42(8):703-20.